Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 12 of the 22 sources its claims cite were checked for support.

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans.

Open access
Vollenweider, P, Randin, D, Tappy, L, Jéquier, E, Nicod, P, Scherrer, U · 1994 · Journal of Clinical Investigation

Abstract

The sympathetic nervous system is an important regulatory mechanism of both metabolic and cardiovascular function, and altered sympathetic activity may play a role in the etiology and/or complications of obesity. In lean subjects, insulin evokes sympathetic activation and vasodilation in skeletal muscle. In obese subjects such vasodilation is impaired and, in turn, may contribute to insulin resistance. To examine the relationship between sympathetic and vasodilatory responses in skeletal muscle to hyperinsulinemia, we simultaneously measured muscle sympathetic nerve activity (MSNA) and calf blood flow at basal and during a 2-h hyperinsulinemic (6 pmol/kg per min) euglycemic clamp in eight lean and eight obese subjects. The major findings of this study are twofold: obese subjects had a 2.2 times higher fasting rate of MSNA, and euglycemic hyperinsulinemia, which more than doubled MSNA and increased calf blood flow by roughly 30% in lean subjects, had only a minor vasodilatory and sympathoexcitatory effect in obese subjects. In contrast, two non-insulin-sympathetic stimuli evoked comparably large increases in MSNA in lean and obese subjects. We conclude that insulin resistance in obese subjects is associated with increased fasting MSNA and a specific impairment of sympathetic neural responsiveness to physiological hyperinsulinemia in skeletal muscle tissue.

Overview

CoChat Summary

TL;DR

In obese humans, fasting muscle sympathetic nerve activity (MSNA) was about 2.2-fold higher than in lean subjects, but hyperinsulinemia failed to normally increase MSNA or calf blood flow. This suggests obesity-related insulin resistance includes a specific impairment of insulin’s sympathoexcitatory and vasodilatory effects in skeletal muscle.

Key findings

  • Obese subjects had higher basal MSNA than lean subjects (37±5 vs 17±3 bursts/min), and euglycemic hyperinsulinemia increased MSNA burst frequency by only 9±3% in obese subjects versus 94±10% in lean subjects (P < 0.05 vs lean).
  • In lean subjects, the 2-h hyperinsulinemic euglycemic clamp increased calf blood flow by 29±5% and decreased calf vascular resistance by 20±3%; in obese subjects it had no detectable effect on calf blood flow or calf vascular resistance.
  • Non-insulin sympathetic stimuli produced comparable MSNA increases in both groups: peak Valsalva responses were 71±8 bursts/min in obese vs 67±4 in lean, and cold pressor responses were 54±6 vs 45±3 bursts/min (P > 0.1).
  • Across all 16 subjects, fasting insulinemia correlated directly with fasting MSNA burst frequency (r = 0.56, P < 0.03), and fasting MSNA was inversely related to glucose uptake during the last 30 min of insulin/glucose infusion (r = 0.68, P < 0.004).

Methods

  • Eight obese subjects (BMI 33.8±1.6 kg/m², age 38±3 yr) and eight age- and sex-matched lean healthy subjects (BMI 22.2±0.7 kg/m², age 37±3 yr) were studied; all were normotensive, had normal glucose tolerance, took no medication, and had no evidence of metabolic or cardiovascular disease.
  • Protocol 1 used a 2-h hyperinsulinemic euglycemic clamp at 1 mU/kg per min (6 pmol/kg per min), with simultaneous MSNA measured by microneurography of the peroneal nerve and calf blood flow measured by venous occlusion plethysmography; non-insulin sympathetic responses were tested with a Valsalva maneuver and cold pressor test.
  • Protocol 2 studied five lean subjects with low-dose 2-h hyperinsulinemic euglycemic clamps at 0.5 and 0.15 mU/kg per min; analysis used ANOVA for repeated measures, paired t tests with Bonferroni adjustment, unpaired t tests, and least-squares correlations, with P < 0.05 considered significant.

Limitations

  • Stated: the paper says its data “do not elucidate the underlying mechanism of insulin-induced sympathetic activation and vasodilation,” and it offers two possible interpretations for the attenuated sympathetic response in obese subjects—resistance to insulin’s sympathoexcitatory effects versus high basal MSNA already near the maximal insulin-induced response.
  • Evident: the main comparison included only eight subjects per group, and the low-dose insulin dose-response studies included only five lean subjects.
  • Evident: obese subjects had significantly higher plasma insulin concentrations during the clamp than lean subjects (643±47 vs 449±48 pmol/liter at 120 min), so the groups were not compared at matched insulinemia; the paper also has no formal limitations section.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci117242

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Segments of simultaneous recordings of MSNA and calf blood flow in a lean (top) and an obese (bottom) subject obtained at basal and during the last 5 min of a 2-h insulin infusion (euglycemic clamp). On these mean voltage displays of MSNA, each peak represents a spontaneous burst of sympathetic discharge. Even though in this obese subject insulin glucose infusion resulted in plasma insulin concentrations that were higher than those observed in this lean subject, they did not have any detectable stimulatory effect on sympathetic nerve activity or blood flow in skeletal muscle.
Figure 1 Segments of simultaneous recordings of MSNA and calf blood flow in a lean (top) and an obese (bottom) subject obtained at basal and during the last 5 min of a 2-h insulin infusion (euglycemic clamp). On these mean voltage displays of MSNA, each peak represents a spontaneous burst of sympathetic discharge. Even though in this obese subject insulin glucose infusion resulted in plasma insulin concentrations that were higher than those observed in this lean subject, they did not have any detectable stimulatory effect on sympathetic nerve activity or blood flow in skeletal muscle.From the PDF
Figure 2 Line graphs showing the effects on plasma insulin concentration, calf vascular resistance, and MSNA of a 2-h insulin infusion (1 mU/kg per min, euglycemic hyperinsulinemic clamp) in lean () and obese (□) subjects. Data represent mean±SE for eight subjects in each group. * P < 0.05 lean vs obese subjects. Even though insulin infusion in obese subjects increased plasma insulin concentrations to significantly higher levels than in lean subjects, such hypi Me o t e e i aen or calf vascular resistance.
Figure 2 Line graphs showing the effects on plasma insulin concentration, calf vascular resistance, and MSNA of a 2-h insulin infusion (1 mU/kg per min, euglycemic hyperinsulinemic clamp) in lean () and obese (□) subjects. Data represent mean±SE for eight subjects in each group. * P < 0.05 lean vs obese subjects. Even though insulin infusion in obese subjects increased plasma insulin concentrations to significantly higher levels than in lean subjects, such hypi Me o t e e i aen or calf vascular resistance.From the PDF
Figure 3 Line graphs showing effects on plasma insulin concentration and changes in calf vascular resistance and MSNA of 2-h insulin infusions in lean subjects performed at three different rates (·—·, 1 mU/kg per min; ∆ — ∆, 0.5 mU/kg per min; □—□, 0.15 mU/kg per min). Data represent mean±SE for five subjects. Even though plasma insulin levels observed at the end of highest and the lowest rates of insulin infusion used differed by roughly threefold, they were associated with increases in MSNA and decreases in calf vascular resistance that were comparable.
Figure 3 Line graphs showing effects on plasma insulin concentration and changes in calf vascular resistance and MSNA of 2-h insulin infusions in lean subjects performed at three different rates (·—·, 1 mU/kg per min; ∆ — ∆, 0.5 mU/kg per min; □—□, 0.15 mU/kg per min). Data represent mean±SE for five subjects. Even though plasma insulin levels observed at the end of highest and the lowest rates of insulin infusion used differed by roughly threefold, they were associated with increases in MSNA and decreases in calf vascular resistance that were comparable.From the PDF

Verification

Claims the paper makes

8 Valid · 2 Not valid · 6 Not checked · 53 Own results and interpretations

44 more claims · 1 with their cited sources checked

Create a free account to see all 69 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 13
  • It may state two separate claims as one. 7
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Citations

Cites

Show all 30 references

Cited by

See all 285

Metadata

Authors
Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
Venue
Journal of Clinical Investigation
Published
1994-06-01
Volume
93
Issue
6
Pages
2365-2371
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2063637050
Cited by
285
References
30
Citations by year
2026: 2 · 2025: 1 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 10 · 2014: 5 · 2013: 3 · 2012: 14
FWCI
7.91
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (36280, 28668)
  • Nestec
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
obesity, insulin resistance, muscle sympathetic nerve activity, skeletal muscle vasodilation, hyperinsulinemic-euglycemic clamp, calf blood flow, sympathetic nervous system, insulin signaling
MeSH terms
Adult, Blood Glucose, Female, Humans, Insulin, Male, Muscles, Obesity, Regional Blood Flow, Sympathetic Nervous System, Vascular Resistance, Vasodilation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. https://app.cochat.ai/papers/10.1172/jci117242
The paper
Vollenweider, P., Randin, D., Tappy, L., Jéquier, E., Nicod, P., & Scherrer, U. (1994). Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. Journal of Clinical Investigation. https://doi.org/10.1172/jci117242

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.